Skip to main content

Day: July 17, 2025

Arq Schedules Second Quarter 2025 Earnings Conference Call

GREENWOOD VILLAGE, Colo., July 17, 2025 (GLOBE NEWSWIRE) — Arq, Inc. (NASDAQ: ARQ) (the “Company” or “Arq”), a producer of activated carbon and other environmentally efficient carbon products for use in purification and sustainable materials, today announced the Company will release its second quarter 2025 financial results and file its Quarterly Report on Form 10-Q for the period ended June 30, 2025, after market close on Monday, August 11, 2025. A conference call to discuss the Company’s financial performance is scheduled for Tuesday, August 12, 2025, at 8:30 a.m. Eastern Time. The conference call webcast information will be available via the Investor Resources section of Arq’s website at www.arq.com. Interested parties may participate in the conference call by registering at https://www.webcast-eqs.com/Arq_Q2_2025....

Continue reading

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, August 7, 2025, at 4:30 p.m. Eastern Time to discuss its results for the second quarter period ended June 30, 2025. The financial results will be issued in a press release prior to the call. OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:Date: Thursday, August 7, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Toll Free: 1-844-825-9789International: 1-412-317-5180Conference ID: 10200608Call me™ Link: https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg==Call...

Continue reading

Dynacor Group Reports Record Sales of $30.8 Million for June 2025 and Record Cumulative Sales of $159.7 Million

MONTREAL, July 17, 2025 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX-DNG) (“Dynacor” or the “Corporation”), today announced unaudited record gold sales of $30.8 million in June and record quarterly sales of $79.7 million. All figures are in US dollars unless otherwise indicated. Monthly HighlightsGold sales reached a record of $30.8 million (C$42.2 million1) in June 2025, compared to $18.7 million (C$25.6 million) in June 2024.The increase in sales of $12.1 million or +64.7% versus June 2024 is due to higher sales price (+50.8%) and an increase in volume (+13.9%).In June, the selling price of gold averaged $3,348 per ounce, compared to $2,313 per ounce, a 44.7% increase over June 2024.          Year To Date HighlightsRecord cumulative gold sales of $159.7 million at the end of June 2025, compared to $135.1 million...

Continue reading

Q-Gold Announces Appointment of Peter Tagliamonte as Chief Executive Officer

TORONTO, July 17, 2025 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR, OTC: QGLDF) (“Q-Gold” or the “Company”) is pleased to announce today the appointment of Peter Tagliamonte, P.Eng. as its Chief Executive Officer. Dr. Andreas Rompel has assumed the role of Chief Operating Officer and VP Exploration and will remain on the board of directors of the Company. Mr. Tagliamonte brings over 30 years of specialized experience in open pit and underground mine development and shaft sinking and extensive experience with low grade open pit mine development and operations. He has a strong track record of managing complex regulatory environments and navigating operational challenges. In recognition of his leadership and contributions to the mining industry, Mr. Tagliamonte was named Mine Manager of the Year by the Mining Journal in 2005—a...

Continue reading

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

WHO WHAT WHEN WHYNuwellis, Inc. Termination of theREVERSE-HF clinicaltrialJuly 17, 2025 To redirect resources towardoutpatient markets where scalableimpact is highest. MINNEAPOLIS, July 17, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. today announced the termination of its REVERSE-HF clinical trial, a randomized post-market trial evaluating ultrafiltration vs. IV loop diuretic therapy for fluid management in hospitalized heart failure patients. This decision reflects the company’s strategic commitment to prioritize resources in areas demonstrating the greatest potential for patient impact and business growth—namely, outpatient heart failure, pediatric, and critical care. “We’re incredibly grateful to the hospitals, investigators, and clinical teams who contributed their time and expertise to REVERSE-HF,” said John Erb, CEO...

Continue reading

Just 3 in 10 aviation executives believe their strategy can adequately address the emerging risk challenges of the next decade

LONDON, July 17, 2025 (GLOBE NEWSWIRE) — 130 senior aviation representatives took part in our new report, Understanding emerging risks in the aviation industry by Willis, a WTW business (NASDAQ:WTW). Of these, only one in two declared themselves confident that their business model and strategy are resilient to today’s emerging risks environment, and only 30% believe their strategy will be fit for purpose over the next decade. In addition, 80% of key decision makers and 90% of those involved in teams leading or implementing risk strategies were unable to identify their organization’s definition of emerging risk. Almost half of the respondents in the sector (49%) were unable to identify their company’s top five emerging risks. Other key findings include:Climate transition: Climate change is viewed as a significant threat to the...

Continue reading

Morien Receives Notice from Kameron to Explore Sale of Donkin Mine Interest

HALIFAX, Nova Scotia, July 17, 2025 (GLOBE NEWSWIRE) — Morien Resources Corp. (“Morien” or the “Company“) (TSX-V:MOX) reports that it has received notice from Kameron Collieries ULC (“Kameron”), owner and operator of the Donkin Coal Mine (the “Donkin Mine”) in Nova Scotia, of Kameron’s intent to explore a sale of its 100% ownership in the Donkin Mine. Under the terms of the Royalty Agreement between Morien and Kameron, Morien holds a 2-4% production royalty on coal sales from the Donkin Mine. This royalty is binding upon Kameron and successor owners of the Donkin Mine and will continue if there is a change in ownership. The Company understands that Kameron is in the early stages of initiating the sale process and has not yet entered into any binding sale agreement with a third party. Kameron’s parent company,...

Continue reading

I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health

Acquisition provides I-Mab with upstream rights to CLDN18.2 parental antibody for use in bispecific and multi-specific applications Acquisition eliminates all royalty obligations and reduces future milestones for givastomig due to Bridge Health by I-MabROCKVILLE, Md., July 17, 2025 (GLOBE NEWSWIRE) — I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that it entered into a definitive agreement to acquire 100% ownership of Bridge Health Biotech Co., Ltd. (Bridge Health). The transaction provides I-Mab with the rights to bispecific and multi-specific applications (including bispecific and multi-specific antibodies and antibody drug conjugates (ADCs)), based on the Claudin 18.2 (CLDN18.2) parental...

Continue reading

Guardian Capital Announces July 2025 Cash Distributions for Guardian Capital ETFs

TORONTO, July 17, 2025 (GLOBE NEWSWIRE) — Guardian Capital LP (the “Manager”) announces the following regular cash distributions for the period ending July 31, 2025, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on July 31, 2025 to unitholders of record on July 25, 2025. The ex-dividend date in each case is anticipated to be July 25, 2025.Guardian Capital ETFs Series of ETF Units DistributionFrequency TradingSymbol Exchange Distribution Amount(per ETF Unit)GuardBondsTM 2025 Investment Grade Bond Fund ETF Units Monthly GBFB Cboe Canada CAD$0.0368GuardBondsTM 2026 Investment Grade Bond Fund ETF Units Monthly GBFC Cboe Canada CAD$0.0260GuardBondsTM 2027 Investment Grade Bond Fund ETF Units Monthly GBFD Cboe Canada CAD$0.0301GuardBondsTM...

Continue reading

Morien Announces Strategic Aggregate Partnership

HALIFAX, Nova Scotia, July 17, 2025 (GLOBE NEWSWIRE) — Morien Resources Corp. (“Morien” or the “Company“) (TSX-V:MOX) is pleased to announce that it has entered into a strategic partnership with a large, U.S. based, regional crushed stone (“aggregate”) operator to jointly identify and permit long-life crushed stone opportunities in Atlantic Canada. Morien has pursued new relationships leveraging its regional expertise and longstanding relationships across Nova Scotia and Atlantic Canada. This effort is aligned with its commitment to unlocking the potential of Atlantic Canada’s high-quality mineral resources that can serve both domestic and export infrastructure markets. This partnership positions Morien to capitalize on Atlantic Canada’s strategic location, deep-water access, and high-quality stone resources...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.